Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
European Society of Cardiology
Pharma
ESC: AZ digs deep on Wainua's surprise ph. 3 failure in ATTR-CM
The detailed results on CARDIO-TTRansform were among the most anticipated readouts at this year’s European Society of Cardiology Congress in Munich.
Fraiser Kansteiner
Aug 29, 2026 1:35pm
Alnylam sees Amvuttra as potential standard of care in ATTR-CM
Aug 30, 2024 10:06am
At ESC, AstraZeneca shows Farxiga's benefits across indications
Aug 28, 2023 10:10am
AZ's Farxiga looks set to gain a key 2nd nod in heart failure
Aug 29, 2022 8:08am
Lexicon aims to make its heart failure case with sotagliflozin
Aug 23, 2021 4:00am
AZ's Farxiga flips script on competitors with 26% CV risk cut
Sep 3, 2019 9:27am
